Press Releases

Report Date Files
Biohaven announces closing of initial public offering and full exercise of underwriters' option to purchase additional shares 15 May 2017 Click to open
Portage's holding in Biohaven 08 May 2017 Click to open
Biohaven announces pricing of its initial public offering of common shares 04 May 2017 Click to open
Portage provides updtaes on its Portfolio companies 11 April 2017 Click to open
Biohaven files registration statement for proposed public offering of its common shares 07 April 2017 Click to open
Portage Announces Spinout of Eygen Limited 30 November 2016 Click to open
Biohaven Raises $80 Million in Private Financing 01 November 2016 Click to open
Portage Q3 2016 Chairman's Letter 14 September 2016 Click to open
Press Release on Chairman's Letter 14 September 2016 Click to open
Portage Announces Appointment of New Director 05 August 2016 Click to open
Biohaven Commences Clinical Testing of BHV-4157 22 July 2016 Click to open
Transcript of July 14th Conference Call 14 July 2016 Click to open
FDA clears Biohaven's Investigational New Drug Application For BHV-4157 and Portage To Hold Investor Conference Call to Provide Business Update 05 July 2016 Click to open
Portage's Further Investment in Biohaven 23 March 2016 Click to open
Portage's Biohaven Orphan Drug Designation Request Granted for the Treatment of Spinocerebellar Ataxia 03 March 2016 Click to open